People: Wistar Institute Director Hilary Koprowski Receives `Philadelphia's Nobel Prize'

Hilary Koprowski, director of the Wistar Institute in Philadelphia, recently was presented with the Philadelphia Award, also referred to as "Philadelphia's Nobel Prize." The annual $25,000 award, originated in 1921 by publisher Edward W. Bok, who died in 1930, is given by a board of trustees established in Bok's will. The honor recognizes outstanding achievement in the Philadelphia area. Previous winners include the Rev. Leon Sullivan and orchestral conductors Eugene Ormandy and Leopold Stokow

Written byColby Stong
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Hilary Koprowski, director of the Wistar Institute in Philadelphia, recently was presented with the Philadelphia Award, also referred to as "Philadelphia's Nobel Prize."

The annual $25,000 award, originated in 1921 by publisher Edward W. Bok, who died in 1930, is given by a board of trustees established in Bok's will. The honor recognizes outstanding achievement in the Philadelphia area. Previous winners include the Rev. Leon Sullivan and orchestral conductors Eugene Ormandy and Leopold Stokowski.

Born in Warsaw, Koprowski, 73, is best known for his work in helping to develop vaccines for rabies and polio. He has been the director of the Wistar Institute, the nation's oldest independent biomedical research center, since 1957.

Koprowski says that he will donate the prize money to the Wistar Institute. "The prize is not really for myself, but for my colleagues," says Koprowski, also professor of microbiology at the University of Pennsylvania.

From 1944 to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies